Hence, tumor development is initiated in committed B cells, but then leads to dedifferentiation of the Pax5Jak2/+ B‐ALL cells due to the loss of Pax5 function similar to what is observed upon conditional Pax5 deletion in pro‐B cells (Mikkola et al, 2002). The gene discussed is PAX5; the disease is neoplasm.